Arbutus Reports First Quarter 2026 Financial Results and Provides Corporate Update

Q1 total revenue of $179.1M includes estimated license revenue from Genevant related to litigation settlement with Moderna
Open original source
Q1 total revenue of $179.1M includes estimated license revenue from Genevant related to litigation settlement with Moderna
Open original source